Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
LPCN > SEC Filings for LPCN > Form 8-K on 10-Feb-2014All Recent SEC Filings

Show all filings for LIPOCINE INC.

Form 8-K for LIPOCINE INC.


10-Feb-2014

Regulation FD Disclosure, Other Events, Financial Statements and Exhibits


Item 7.01 Regulation FD Disclosure

The Company is presenting at the Leerink Global Healthcare Conference to be held February 12-13, 2014. Additionally before and during the conference, the Company will be meeting with investors and presenting materials to investors regarding the Company. The Company's materials to be used in the presentations and investor meetings are attached hereto as Exhibit 99.2.



Item 8.01 Other Events

On February 10, 2014, Lipocine Inc. issued a press release to report the first patient dosed in its Phase 3 Study for Oral Testosterone Replacement Therapy ("SOAR") clinical trial. The press release is furnished as Exhibit 99.1 and is incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are furnished with this report:

Exhibit No.   Description

99.1          Press Release Announcing First Patient Dosed in Phase 3 Study for
              Oral Testosterone Replacement Therapy

99.2          Company Presentation

  Add LPCN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for LPCN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.